| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M203489200 |
| P698 | PubMed publication ID | 12015325 |
| P50 | author | Rolf Renne | Q74933237 |
| P2093 | author name string | Jianhong Hu | |
| Alexander C Garber | |||
| P2860 | cites work | Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 |
| Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| 57 Sequencing end-labeled DNA with base-specific chemical cleavages | Q27860479 | ||
| Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus | Q37637247 | ||
| Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters | Q39602154 | ||
| Interactions of USF and Ku antigen with a human DNA region containing a replication origin | Q40408378 | ||
| The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus | Q40746913 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | Q40811288 | ||
| The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1 | Q40818766 | ||
| Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies | Q40914940 | ||
| The Structure and Coding Organization of the Genomic Termini of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) | Q41090568 | ||
| Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function | Q41179765 | ||
| Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells | Q41334221 | ||
| Deletion analysis of minimal sequence requirements for autonomous replication of ors8, a monkey early-replicating DNA sequence | Q41375438 | ||
| Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator | Q41710155 | ||
| SV40 gene expression is modulated by the cooperative binding of T antigen to DNA | Q43915434 | ||
| A common function for polyoma virus large-T and papillomavirus E1 proteins? | Q45807494 | ||
| Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product | Q45838465 | ||
| Association of the Origin Recognition Complex with Heterochromatin and HP1 in Higher Eukaryotes | Q46408897 | ||
| Aberrant replication timing induces defective chromosome condensation in Drosophila ORC2 mutants | Q47071017 | ||
| The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus | Q57662902 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin | Q28213116 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| A yeast chromosomal origin of DNA replication defined by multiple functional elements | Q28679255 | ||
| Product review. New mammalian expression vectors | Q29620743 | ||
| Stimulation of DNA replication in Saccharomyces cerevisiae by a glutamine- and proline-rich transcriptional activation domain | Q30304323 | ||
| The minimal replicator of Epstein-Barr virus oriP. | Q33804269 | ||
| Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33835021 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. | Q33838228 | ||
| DNA replication efficiency depends on transcription factor-binding sites | Q33842004 | ||
| The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements | Q33848552 | ||
| Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes | Q33851443 | ||
| DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33853499 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt | Q33891311 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus | Q33942957 | ||
| Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus | Q34081126 | ||
| Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. | Q34107917 | ||
| The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication. | Q34583809 | ||
| Control of HPV 18 DNA replication by cellular and viral transcription factors. | Q34782217 | ||
| Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication | Q36068854 | ||
| Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1 | Q36092884 | ||
| The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase | Q36336279 | ||
| Transcription inhibits the replication of autonomously replicating plasmids in human cells | Q36650272 | ||
| A mammalian origin of bidirectional DNA replication within the Chinese hamster RPS14 locus | Q36664334 | ||
| Isolation of human sequences that replicate autonomously in human cells | Q36767535 | ||
| A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components | Q36891387 | ||
| trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. | Q36899288 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27401-27411 | |
| P577 | publication date | 2002-05-15 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication | |
| P478 | volume | 277 |
| Q39756815 | A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin |
| Q40605014 | A Role for the Internal Repeat of the Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen in the Persistence of an Episomal Viral Genome |
| Q27680409 | A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins |
| Q37380221 | A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence |
| Q34648229 | Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. |
| Q42277624 | Analysis of Kaposi's sarcoma-associated herpesvirus latent replication using a real-time polymerase chain reaction technique |
| Q36098894 | Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance |
| Q30398275 | Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes |
| Q34092739 | Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. |
| Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
| Q33781363 | Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin |
| Q33729584 | Chromatin organization of gammaherpesvirus latent genomes |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q40041231 | Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA. |
| Q27680412 | Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency |
| Q41675761 | Crystallization, room-temperature X-ray diffraction and preliminary analysis of Kaposi's sarcoma herpesvirus LANA bound to DNA. |
| Q36646579 | Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS |
| Q37682920 | Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA. |
| Q35785433 | Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding |
| Q36691938 | Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus |
| Q28473633 | Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening |
| Q40163096 | Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence |
| Q39744147 | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas |
| Q37476243 | Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication |
| Q59351017 | Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus |
| Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
| Q34348453 | Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. |
| Q36760020 | H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence |
| Q30479353 | HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus |
| Q40192261 | Herpesvirus Latency: On the Importance of Positioning Oneself. |
| Q35086996 | Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies |
| Q81037620 | Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies |
| Q35943531 | Identification of Host-Chromosome Binding Sites and Candidate Gene Targets for Kaposi's Sarcoma-Associated Herpesvirus LANA |
| Q37254389 | Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence |
| Q28505713 | Identification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral Replication |
| Q24646461 | Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q40364647 | Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. |
| Q35208258 | Influence of ND10 components on epigenetic determinants of early KSHV latency establishment |
| Q41886930 | Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells |
| Q33221441 | Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. |
| Q36954898 | Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. |
| Q37410861 | Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus |
| Q60178445 | KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q36676548 | KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA. |
| Q30433391 | KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation |
| Q28474913 | KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA |
| Q26738483 | Kaposi's Sarcoma Herpesvirus Genome Persistence |
| Q34997083 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells |
| Q39265271 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence |
| Q34841987 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Down-Regulates IL-22R1 Expression through a Cis-Acting Element within the Promoter Region |
| Q40231171 | Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes |
| Q41846091 | Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation |
| Q40128647 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing |
| Q42584460 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. |
| Q24673761 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes |
| Q35185944 | Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q39833695 | Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis |
| Q35691156 | Kaposi’s Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency |
| Q28540872 | LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex |
| Q40241802 | Lack of a mechanism for faithful partition and maintenance of the KSHV genome |
| Q40317413 | Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats |
| Q40682995 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. |
| Q34276926 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha. |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q39406147 | Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Monocytes Downregulates Expression of Adaptive Immune Response Costimulatory Receptors and Proinflammatory Cytokines |
| Q36223625 | Linking KSHV to human cancer |
| Q35678361 | Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers |
| Q34437977 | Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus |
| Q27680411 | Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q36363318 | Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence |
| Q34734774 | Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins |
| Q40276488 | ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin |
| Q40173321 | ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis -Acting DNA Sequences in the Terminal Repeats |
| Q35841060 | Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis |
| Q28285357 | Pathogenesis of gammaherpesvirus infections |
| Q52731162 | Plasmid Partitioning by Human Tumor Viruses |
| Q40292424 | Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus |
| Q24538878 | Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes |
| Q41866484 | Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins |
| Q35134498 | Rapid and quantitative assessment of KSHV LANA-mediated DNA replication |
| Q35080754 | Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA |
| Q34292265 | Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q41849965 | Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q37157253 | Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence |
| Q34774847 | SUMO and KSHV Replication |
| Q57144270 | Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers |
| Q40605206 | Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. |
| Q52722164 | Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether |
| Q36968066 | Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors |
| Q51831648 | Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence |
| Q35669267 | The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA |
| Q35140238 | The Internal Kaposi's Sarcoma-Associated Herpesvirus LANA Regions Exert a Critical Role on Episome Persistence |
| Q36301221 | The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence. |
| Q36099076 | The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc |
| Q34553975 | The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence |
| Q38725485 | The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency |
| Q41860564 | The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains |
| Q39700420 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. |
| Q34355092 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells |
| Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
| Q40199723 | The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner |
| Q37252776 | The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
| Q30155970 | Thermodynamics of cooperative DNA recognition at a replication origin and transcription regulatory site. |
| Q38318452 | Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability |
| Q39960021 | Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. |
| Q34411851 | Unbiased Mutagenesis of MHV68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo |
| Q39702331 | Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection |
| Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
| Q59349239 | Visualization of molecular biology: The LANA tether |
Search more.